Literature DB >> 31662544

A Population-based Statistical Model for Investigating Heterogeneous Intraprostatic Sensitivity to Radiation Toxicity After 125I Seed Implantation.

Kazuma Kobayashi1,2,3, Naoya Murakami4, Kana Takahashi4, Koji Inaba4, Hiroshi Igaki4, Ryuji Hamamoto5,2,3, Jun Itami4.   

Abstract

AIM: To develop a population-based statistical model in order to find a spatial pattern of dose distribution which is related to lower urinary tract symptoms (LUTS) after iodine-125 (125I) seed implantation for prostate cancer. PATIENTS AND METHODS: A total of 75 patients underwent 125I seed implantation for prostate cancer. Principal component analysis was applied to the standardized dose array and for each patient dose distribution was uniquely characterized by a combination of weighted eigenvectors. The correlation between eigenvectors and the severity of LUTS was investigated with linear regression analysis.
RESULTS: Eight eigenvectors were identified as being significantly associated with the severity of LUTS (p<0.05). Multivariate regression model identified that intraprostatic parameters, which were positively associated with the severity of LUTS, were distributed around a portion of the urethral base and a peripheral region of the prostate.
CONCLUSION: We established a population-based statistical model that may indicate a significant dose pattern associated with the severity of radiation toxicity. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Prostate cancer; brachytherapy; heterogeneous intra-organ radiosensitivity; non-rigid registration; principal component analysis

Mesh:

Substances:

Year:  2019        PMID: 31662544      PMCID: PMC6899147          DOI: 10.21873/invivo.11710

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  40 in total

1.  Dosimetric variations due to interfraction organ deformation in cervical cancer brachytherapy.

Authors:  Kazuma Kobayashi; Naoya Murakami; Akihisa Wakita; Satoshi Nakamura; Hiroyuki Okamoto; Rei Umezawa; Kana Takahashi; Koji Inaba; Hiroshi Igaki; Yoshinori Ito; Naoyuki Shigematsu; Jun Itami
Journal:  Radiother Oncol       Date:  2015-08-24       Impact factor: 6.280

2.  Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.

Authors:  Marion P R Van Gellekom; Marinus A Moerland; Marco Van Vulpen; Harm K Wijrdeman; Jan J Battermann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-20       Impact factor: 7.038

3.  12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer.

Authors:  Louis Potters; Carol Morgenstern; Emil Calugaru; Paul Fearn; Anup Jassal; Joseph Presser; Edward Mullen
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

4.  Decline in urinary retention incidence in 805 patients after prostate brachytherapy: the effect of learning curve?

Authors:  Mira Keyes; Devin Schellenberg; Veronika Moravan; Michael McKenzie; Alexander Agranovich; Tom Pickles; Jonn Wu; Mitchell Liu; Joseph Bucci; W James Morris
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-01       Impact factor: 7.038

5.  Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.

Authors:  Michael J Zelefsky; Deborah A Kuban; Larry B Levy; Louis Potters; David C Beyer; John C Blasko; Brian J Moran; Jay P Ciezki; Anthony L Zietman; Thomas M Pisansky; Mohamed Elshaikh; Eric M Horwitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-02       Impact factor: 7.038

6.  Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds.

Authors:  David Bottomley; Dan Ash; Bashar Al-Qaisieh; Brendan Carey; Joji Joseph; Shaun St Clair; Kathy Gould
Journal:  Radiother Oncol       Date:  2006-12-11       Impact factor: 6.280

Review 7.  Complications following permanent prostate brachytherapy.

Authors:  N N Stone; R G Stock
Journal:  Eur Urol       Date:  2002-04       Impact factor: 20.096

8.  Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.

Authors:  Peter Wust; Daniel Wischka von Borczyskowski; Thomas Henkel; Christian Rosner; Reinhold Graf; Wolfgang Tilly; Volker Budach; Roland Felix; Frank Kahmann
Journal:  Radiother Oncol       Date:  2004-10       Impact factor: 6.280

9.  Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markers.

Authors:  Gerard J van der Wielen; Theodore F Mutanga; Luca Incrocci; Wim J Kirkels; Eliana M Vasquez Osorio; Mischa S Hoogeman; Ben J M Heijmen; Hans C J de Boer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-01       Impact factor: 7.038

10.  Machine Learning Methods Uncover Radiomorphologic Dose Patterns in Salivary Glands that Predict Xerostomia in Patients with Head and Neck Cancer.

Authors:  Wei Jiang; Pranav Lakshminarayanan; Xuan Hui; Peijin Han; Zhi Cheng; Michael Bowers; Ilya Shpitser; Sauleh Siddiqui; Russell H Taylor; Harry Quon; Todd McNutt
Journal:  Adv Radiat Oncol       Date:  2018-11-29
View more
  1 in total

1.  Tensor Regression-based Model to Investigate Heterogeneous Spatial Radiosensitivity After I-125 Seed Implantation for Prostate Cancer.

Authors:  Kazuma Kobayashi; Naoya Murakami; Kana Takahashi; Koji Inaba; Hiroshi Igaki; Ryuji Hamamoto; Jun Itami
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.